Link Technologies Ltd was established in the West of Scotland in 1989 and has since built an enviable global reputation as a supplier of …
READ MOREEvent Information
This is an external event.
Monday 06 September, 2010 to Wednesday 08 September, 2010
Edinburgh
Faraday Discussion 149: Analysis for Healthcare Diagnostics and Theranostics
Faraday Discussion 149: Analysis for Healthcare Diagnostics and Theranostics
6 - 8 September 2010
University of Edinburgh, United Kingdom
Call for poster abstracts deadline - 2 July 2010
Introduction
The need in healthcare to detect biomolecular species such as proteins, oligonucleotides (DNA and RNA) and cells for diagnostics is driving the current development of physical techniques. The development is generally based on optical, electrochemical and mass spectrometric transduction to enable these measurements. These are now also being exploited in array formats, enabling the development of high throughput detection to inform systems biology and pathway medicine by giving new insights into biomolecular pathways and the identification of new target analytes.
This is a highly topical and exciting area which opens up the real prospect of theranostics (the use of diagnostics in informing patient specific therapy), but for which development and optimisation of detection requires an understanding and control of the fundamental physical processes occurring both in sensing and in signal transduction and the comparatives merits of alternative detection strategies. For high throughput detection, bioinformatics (the processing and interpretation of vast amounts of data) also presents a real challenge.
Aims
Faraday Discussion 149, organised by the Faraday Division, aims to bring together scientists from many disciplines, including biologists, physicists and chemists, involving academics and industrialists from the healthcare and biosensing communities.
Themes
Systems/Devices to Inform Therapy (SDIT)
Physical Techniques for Diagnostics (PTD)
High-Throughput Measurement and Analysis (HTMA)
Towards Real-time Clinical Measurement (TRCM)
Co-sponsors
We are grateful to the International Society of Electrochemistry (ISE) for their co-sponsorship support of FD149. Members of the ISE are eligible to register to attend FD149 at the discounted RSC member rate.
Scientific Committee
Dr Andrew Mount (University of Edinburgh, UK) (Chair)
Dr Till Bachmann (University of Edinburgh, UK)
Professor Phil Bartlett (University of Southampton, UK)
Professor Rob Beynon (University of Liverpool, UK)
Professor Mark Bradley (University of Edinburgh, UK)
Professor Paul French (Imperial College London, UK)
Dr David Mendels (Cognoscens, France)
Please see the Conference website for further information.
Contact and Further Information RSC Conferences
Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge CB4 0WF, UK
Tel: +44 (0) 1223 432380 / 432254
Fax: +44 (0) 1223 423623



